Invention Grant
US08173132B2 Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer
失效
核酸和相应的蛋白质213P1F11可用于治疗和检测癌症
- Patent Title: Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer
- Patent Title (中): 核酸和相应的蛋白质213P1F11可用于治疗和检测癌症
-
Application No.: US12357253Application Date: 2009-01-21
-
Publication No.: US08173132B2Publication Date: 2012-05-08
- Inventor: Pia M. Challita-Eid , Arthur B. Raitano , Mary Faris , Rene S. Hubert , Robert Kendall Morrison , Wangmao Ge , Aya Jakobovits
- Applicant: Pia M. Challita-Eid , Arthur B. Raitano , Mary Faris , Rene S. Hubert , Robert Kendall Morrison , Wangmao Ge , Aya Jakobovits
- Applicant Address: US CA Santa Monica
- Assignee: Agensys, Inc.
- Current Assignee: Agensys, Inc.
- Current Assignee Address: US CA Santa Monica
- Agency: Morrison & Foerster LLP
- Main IPC: A61K39/00
- IPC: A61K39/00
Abstract:
A novel gene (designated 213P1F11) and its encoded protein, and variants thereof, are described wherein 213P1F11 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 213P1F11 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 213P1F11 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 213P1F11 can be used in active or passive immunization.
Public/Granted literature
- US20090181891A1 NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 213P1F11 USEFUL IN TREATMENT AND DETECTION OF CANCER Public/Granted day:2009-07-16
Information query
